封面
市場調查報告書
商品編碼
1363118

計算生物學市場規模、佔有率、趨勢分析報告:按服務、用途、最終用途、地區和細分市場預測,2023-2030 年

Computational Biology Market Size, Share & Trends Analysis Report By Service (Database, Infrastructure & Hardware, Software Platform), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

計算生物學市場成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計到2030年,全球計算生物學市場規模將達到132.5億美元,複合年複合成長率為13.17%。

癌症研究領域研發投入的增加、個體化藥物需求的增加以及活性化的藥物研發研究預計將有助於市場開拓。此外,生物技術產業的不斷進步和人工智慧技術的採用將進一步推動預測期內的市場成長。

遺傳分析中先進技術的日益採用正在推動計算生物學市場的成長。例如,2023 年 1 月,Qiagen Digital Insights (QDI) 宣布推出專為超快次世代定序(NGS) 分析而設計的增強型產品。這項創新解決方案只需 25 分鐘即可處理整個基因組,雲端運算成本為 1 美元。這預計將使研究人員能夠有效地分析和解釋來自各種定序方法的資料,包括全基因組定序(WGS)、全外顯子定序(WES)和大規模面板定序。因此,預計將在預測期內推動市場成長。

此外,根據 Cryptopolitan 於 2023 年 9 月發表的報導,浦項科技大學 (POSTECH) 的科學家們開發了一種機器,可以在臨床試驗之前估計新藥獲得核准的可能性,這是一項重大進展.在《EBioMedicine》雜誌上共用了我們透過學習獲得的發現。預計這將有助於了解臨床試驗期間的藥物失敗率。因此,技術進步的不斷進步預計將在預測期內推動市場成長。

然而,生物系統的複雜性和該領域熟練專業人員的缺乏預計將阻礙市場的成長。生物系統非常複雜,準確地對其行為進行建模非常困難,並且需要熟練且訓練有素的專家的存在。許多生物過程涉及複雜的網路和相互作用,進一步增加了分析的複雜性,在某些情況下,使得計算預測不太可靠。

計算生物學市場報告亮點

  • 按服務分類,軟體和平台領域市場預計將在 2022 年以 39.06% 的佔有率主導市場,並在預測期內以最快的年複合成長率成長。這是由於藥物研發和開發的增加以及對個體化藥物的需求增加。
  • 從用途來看,臨床試驗領域佔據市場主導地位,2022年市佔率為26.84%。這主要是由於該領域研究和開發活動的增加。
  • 依最終用途,工業領域佔最大市場佔有率,2022 年將達到 62.10%。這是由於藥物研發、標鑒定、虛擬篩選和藥物動力學建模等其他用途的研究活動增加。
  • 2022年,由於主要市場參與者和強大的醫療基礎設施的存在,北美以48.93%的佔有率主導市場。預計這些將在預測期內推動該地區的計算生物學市場。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 變數、趨勢、範圍

  • 市場體系預測
  • 市場趨勢及展望
  • 市場動態
  • 市場抑制因素分析
  • 營商環境分析

第4章 按服務分類的業務分析

  • 計算生物學市場:服務變化分析
  • 資料庫
  • 基礎設施和硬體
  • 軟體平台

第5章 按用途的業務分析

  • 計算生物學市場:用途變化分析
  • 藥物研發與疾病建模
  • 臨床前藥物開發
  • 臨床試驗
  • 計算基因組學
  • 計算蛋白質體學
  • 其他

第6章 最終用途的業務分析

  • 計算生物學市場:最終用途變異分析
  • 學術與研究
  • 產業

第7章 區域業務分析

  • 區域市場簡介
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率/地位分析
  • 公司簡介/名單
    • DNAnexus, Inc.
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Schrodinger, Inc.
    • Compugen
    • Aganitha AI Inc.
    • Genedata AG
    • QIAGEN
    • SIMULATIONS PLUS
    • Fios Genomics
Product Code: 978-1-68038-212-9

Computational Biology Market Growth & Trends:

The global computational biology market size is expected to reach a value of USD 13.25 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 13.17%. The growing investments in research & development within the fields of cancer research, increasing demand for personalized medicines, and rising drug discovery & development are anticipated to contribute to the growth of the market. Moreover, the increasing advancements in the biotechnology industry and the adoption of artificial intelligence technology will further drive the market growth over the forecast period.

The growing adoption of advanced technology in gene analysis is propelling the growth of the market for computational biology. For instance, in January 2023, Qiagen Digital Insights (QDI) introduced an enhanced product designed for ultra-rapid next-generation sequencing (NGS) analysis. This innovative solution enables the processing of the entire genome within just 25 minutes, for USD 1 in cloud computing expenses. This is anticipated to empower researchers to efficiently analyze and interpret data from various sequencing approaches, including whole genome sequencing (WGS), whole exome sequencing (WES), and large panel sequencing. Hence, it is anticipated to impel market growth over the forecast period.

Furthermore, according to the article published by Cryptopolitan in September 2023, in a major advance development, scientists at Pohang University of Science and Technology (POSTECH) have shared their discoveries in the EBioMedicine journal, that they have used machine learning to estimate the chances of a new drug getting approved even before the clinical trials. This is expected to help in understanding the rate of drug failure at the time of clinical trials. Thus, the rising advancements in technology are anticipated to fuel the growth of the market over the forecast period.

However, the complexity of the biological systems and the lack of skilled professionals in the field are anticipated to hinder the growth of the market. Biological systems are incredibly complex, and accurately modeling their behavior can be challenging and requires the presence of skilled and trained professionals. Many biological processes involve complicated networks and interactions, which further add to the complexity of analysis and make computational predictions less reliable in some cases.

Computational Biology Market Report Highlights:

  • Based on service, the software & platform segment dominated the market with a share of 39.06% in 2022, and the same is anticipated to grow at the fastest CAGR over the forecast period. This can be attributed to the rising drug discovery & development and growing demand for personalized medicines
  • Based on application, the clinical trials segment dominated the market with a share of 26.84% in 2022. This was primarily due to an increase in the number of R&D initiatives in this field.
  • Based on end-use, the industrial segment held the largest market share of 62.10% in 2022. This can be attributed to the increasing research activities for drug discovery, target identification, virtual screening, and pharmacokinetic modeling, among other applications
  • In 2022, North America dominated the market with a share of 48.93%, owing to the presence of major market players, and robust healthcare infrastructure. These are anticipated to boost the market for computational biology in the region over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Growing Adoption Of Bioinformatics Technology
    • 3.3.2. Advancements In Genomic Research
    • 3.3.3. Increasing Demand For Personalized Medicines
  • 3.4. Market Restraint Analysis
    • 3.4.1. Lack of Skilled Professional
    • 3.4.2. Data Privacy And Security Concerns
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Business Analysis

  • 4.1. Computational Biology Market: Service Movement Analysis
  • 4.2. Databases
    • 4.2.1. Databases Market, 2018 - 2030 (USD Million)
  • 4.3. Infrastructure & Hardware
    • 4.3.1. Infrastructure & Hardware, 2018 - 2030 (USD Million)
  • 4.4. Software Platform
    • 4.4.1. Software Platform Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Computational Biology Market: Application Movement Analysis
  • 5.2. Drug Discovery & Disease Modelling
    • 5.2.1. Drug Discovery & Disease Modelling Market, 2018 - 2030 (USD Million)
    • 5.2.2. Target Identification
      • 5.2.2.1. Target Identification Market, 2018 - 2030 (USD Million)
    • 5.2.3. Target Validation
      • 5.2.3.1. Target Validation Market, 2018 - 2030 (USD Million)
    • 5.2.4. Lead Discovery
      • 5.2.4.1. Lead Discovery Market, 2018 - 2030 (USD Million)
    • 5.2.5. Lead Optimization
      • 5.2.5.1. Lead Optimization Market, 2018 - 2030 (USD Million)
  • 5.3. Preclinical Drug Development
    • 5.3.1. Preclinical Drug Development Market, 2018 - 2030 (USD Million)
    • 5.3.2. Pharmacokinetics
      • 5.3.2.1. Pharmacokinetics Market, 2018 - 2030 (USD Million)
    • 5.3.3. Pharmacodynamics
      • 5.3.3.1. Pharmacodynamics Market, 2018 - 2030 (USD Million)
  • 5.4. Clinical Trials
    • 5.4.1. Clinical Trials Market, 2018 - 2030 (USD Million)
    • 5.4.2. Phase I
      • 5.4.2.1. Phase I Market, 2018 - 2030 (USD Million)
    • 5.4.3. Phase II
      • 5.4.3.1. Phase II Market, 2018 - 2030 (USD Million)
    • 5.4.4. Phase III
      • 5.4.4.1. Phase III Market, 2018 - 2030 (USD Million)
    • 5.4.5. Phase IV
      • 5.4.5.1. Phase IV Market, 2018 - 2030 (USD Million)
  • 5.5. Computational Genomics
    • 5.5.1. Computational Genomics Market, 2018 - 2030 (USD Million)
  • 5.6. Computational Proteomics
    • 5.6.1. Computational Proteomics Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Computational Biology Market: End-use Movement Analysis
  • 6.2. Academic & Research
    • 6.2.1. Academic & Research Market, 2018 - 2030 (USD Million)
  • 6.3. Industrial
    • 6.3.1. Industrial Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Competitive Scenario
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Competitive Scenario
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.4.2. Key Country Dynamics
      • 7.5.4.3. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. DNAnexus, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Illumina, Inc.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Schrodinger, Inc.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Compugen
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Aganitha AI Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Genedata AG
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. QIAGEN
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. SIMULATIONS PLUS
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Fios Genomics
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America computational biology market, by country, 2018 - 2030 (USD million)
  • Table 4 North America computational biology market, by service, 2018 - 2030 (USD million)
  • Table 5 North America computational biology market, by application, 2018 - 2030 (USD million)
  • Table 6 North America computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 7 U.S. computational biology market, by service, 2018 - 2030 (USD million)
  • Table 8 U.S computational biology market, by application, 2018 - 2030 (USD million)
  • Table 9 U.S computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 10 Canada computational biology market, by service, 2018 - 2030 (USD million)
  • Table 11 Canada computational biology market, by application, 2018 - 2030 (USD million)
  • Table 12 Canada computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 13 Europe computational biology market, by country, 2018 - 2030 (USD million)
  • Table 14 Europe computational biology market, by service, 2018 - 2030 (USD million)
  • Table 15 Europe computational biology market, by application, 2018 - 2030 (USD million)
  • Table 16 Europe computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 17 UK computational biology market, by service, 2018 - 2030 (USD million)
  • Table 18 UK computational biology market, by application, 2018 - 2030 (USD million)
  • Table 19 UK computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 20 Germany computational biology market, by service, 2018 - 2030 (USD million)
  • Table 21 Germany computational biology market, by application, 2018 - 2030 (USD million)
  • Table 22 Germany computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 23 France computational biology market, by service, 2018 - 2030 (USD million)
  • Table 24 France computational biology market, by application, 2018 - 2030 (USD million)
  • Table 25 France computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 26 Italy computational biology market, by service, 2018 - 2030 (USD million)
  • Table 27 Italy computational biology market, by application, 2018 - 2030 (USD million)
  • Table 28 Italy computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 29 Spain computational biology market, by service, 2018 - 2030 (USD million)
  • Table 30 Spain computational biology market, by application, 2018 - 2030 (USD million)
  • Table 31 Spain computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 32 Denmark computational biology market, by service, 2018 - 2030 (USD million)
  • Table 33 Denmark computational biology market, by application, 2018 - 2030 (USD million)
  • Table 34 Denmark computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 35 Sweden computational biology market, by service, 2018 - 2030 (USD million)
  • Table 36 Sweden computational biology market, by application, 2018 - 2030 (USD million)
  • Table 37 Sweden computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 38 Norway computational biology market, by service, 2018 - 2030 (USD million)
  • Table 39 Norway computational biology market, by application, 2018 - 2030 (USD million)
  • Table 40 Norway computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 41 Asia Pacific computational biology market, by country, 2018 - 2030 (USD million)
  • Table 42 Asia Pacific computational biology market, by service, 2018 - 2030 (USD million)
  • Table 43 Asia Pacific computational biology market, by application, 2018 - 2030 (USD million)
  • Table 44 Asia Pacific computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 45 China computational biology market, by service, 2018 - 2030 (USD million)
  • Table 46 China computational biology market, by application, 2018 - 2030 (USD million)
  • Table 47 China computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 48 Japan computational biology market, by service, 2018 - 2030 (USD million)
  • Table 49 Japan computational biology market, by application, 2018 - 2030 (USD million)
  • Table 50 Japan computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 51 India computational biology market, by service, 2018 - 2030 (USD million)
  • Table 52 India computational biology market, by application, 2018 - 2030 (USD million)
  • Table 53 India computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 54 South Korea computational biology market, by service, 2018 - 2030 (USD million)
  • Table 55 South Korea computational biology market, by application, 2018 - 2030 (USD million)
  • Table 56 South Korea computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 57 Australia computational biology market, by service, 2018 - 2030 (USD million)
  • Table 58 Australia computational biology market, by application, 2018 - 2030 (USD million)
  • Table 59 Australia computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 60 Thailand computational biology market, by service, 2018 - 2030 (USD million)
  • Table 61 Thailand computational biology market, by application, 2018 - 2030 (USD million)
  • Table 62 Thailand computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 63 Latin America computational biology market, by country, 2018 - 2030 (USD million)
  • Table 64 Latin America computational biology market, by service, 2018 - 2030 (USD million)
  • Table 65 Latin America computational biology market, by application, 2018 - 2030 (USD million)
  • Table 66 Latin America computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 67 Brazil computational biology market, by service, 2018 - 2030 (USD million)
  • Table 68 Brazil computational biology market, by application, 2018 - 2030 (USD million)
  • Table 69 Brazil computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 70 Mexico computational biology market, by service, 2018 - 2030 (USD million)
  • Table 71 Mexico computational biology market, by application, 2018 - 2030 (USD million)
  • Table 72 Mexico computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 73 Argentina computational biology market, by service, 2018 - 2030 (USD million)
  • Table 74 Argentina computational biology market, by application, 2018 - 2030 (USD million)
  • Table 75 Argentina computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 76 Middle East & Africa computational biology market, by country, 2018 - 2030 (USD million)
  • Table 77 Middle East & Africa computational biology market, by service, 2018 - 2030 (USD million)
  • Table 78 Middle East & Africa computational biology market, by application, 2018 - 2030 (USD million)
  • Table 79 Middle East & Africa computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 80 South Africa computational biology market, by service, 2018 - 2030 (USD million)
  • Table 81 South Africa computational biology market, by application, 2018 - 2030 (USD million)
  • Table 82 South Africa computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 83 Saudi Arabia computational biology market, by service, 2018 - 2030 (USD million)
  • Table 84 Saudi Arabia computational biology market, by application, 2018 - 2030 (USD million)
  • Table 85 Saudi Arabia computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 86 UAE computational biology market, by service, 2018 - 2030 (USD million)
  • Table 87 UAE computational biology market, by application, 2018 - 2030 (USD million)
  • Table 88 UAE computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 89 Kuwait computational biology market, by service, 2018 - 2030 (USD million)
  • Table 90 Kuwait computational biology market, by application, 2018 - 2030 (USD million)
  • Table 91 Kuwait computational biology market, by end-use, 2018 - 2030 (USD million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market Segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global computational biology market- Key market driver analysis
  • Fig. 7 Global computational biology market - Key market restraint analysis
  • Fig. 8 Global computational biology market - Porter's analysis
  • Fig. 9 Global computational biology market - PESTEL analysis
  • Fig. 10 Global computational biology market: Service outlook key takeaways
  • Fig. 11 Global computational biology market: Service movement analysis
  • Fig. 12 Databases market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Infrastructure & hardware market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Software platform market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Global computational biology market: Application outlook key takeaways
  • Fig. 16 Global computational biology market: Application movement analysis
  • Fig. 17 Drug discovery & disease modeling market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Target identification market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Target validation market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Lead discovery market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Lead optimization market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Preclinical drug development market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacokinetics market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Pharmacodynamics market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Clinical trials market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Phase I market estimates, 2018 - 2030 (USD Million)
  • Fig. 27 Phase II market estimates, 2018 - 2030 (USD Million)
  • Fig. 28 Phase III market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Phase IV market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Computational genomics market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Computational proteomics market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global computational biology market: End-use outlook key takeaways
  • Fig. 34 Global computational biology market: End-use movement analysis
  • Fig. 35 Academic & research market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Industrial market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Global computational biology market: Regional movement analysis
  • Fig. 39 North America computational biology market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. computational biology market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada computational biology market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe computational biology market, 2018 - 2030 (USD Million)
  • Fig. 43 UK computational biology market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany computational biology market, 2018 - 2030 (USD Million)
  • Fig. 45 France computational biology market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain computational biology market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy computational biology market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark computational biology market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden computational biology market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway computational biology market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific computational biology market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan computational biology market, 2018 - 2030 (USD Million)
  • Fig. 53 China computational biology market, 2018 - 2030 (USD Million)
  • Fig. 54 India computational biology market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea computational biology market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia computational biology market, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand computational biology market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America computational biology market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil computational biology market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico computational biology market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina computational biology market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA computational biology market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa computational biology market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia computational biology market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE computational biology market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait computational biology market, 2018 - 2030 (USD Million)
  • Fig. 67 Strategy framework